If you run the numbers and assume a certain return on cash--in the 3.5% to 4.0% range--it may be one or two pennies accretive
I don't think Illumina has anything brewing on the merger and acquisition front that would be materially dilutive or problematic, though ... Some people may just be reading too much into this.
Stephen brings to Illumina nearly 20 years of experience in both Life Sciences and Molecular Diagnostics ... His career history and recent experience with shaping molecular diagnostic strategies will help us prepare to enter this new market.
Our HD BeadChips feature up to 2.3 million SNPs per chip and provide researchers with significant advances, including increased sample throughput, lower input sample volume, and improvements to the Infinium assay that enhance overall system performance